More tools:Markets·Screener·Research·Chat

Liquidia Corporation Common Stock (LQDA) Financial Statements

Liquidia Corporation Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001V0GFD7
XNAS · usd
68.68▲ 1.00 (1.48%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value—
Trailing P/E
Price / Sales
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt—
Trading Information
Previous Close67.68
Day's Range67.07 – 69.21
52-Week Range21.15 – 93.61
Volume1.3M
Avg Volume1.4M
Share Statistics
Shares Outstanding
Employees216
ExchangeXNAS
Listed2018-07-26
Share count as of July 29, 2026
Loading Income Statement…
Key questions about Liquidia Corporation Common Stock (LQDA)
What is Liquidia Corporation Common Stock's Market Cap?
Liquidia Corporation Common Stock's Market Cap is $6.1B, based on as-reported figures from SEC (XBRL) filings.
What is Liquidia Corporation Common Stock's Trailing P/E?
Liquidia Corporation Common Stock's Trailing P/E is 44.4×, based on as-reported figures from SEC (XBRL) filings.
What is Liquidia Corporation Common Stock's Price / Sales?
Liquidia Corporation Common Stock's Price / Sales is 13.6×, based on as-reported figures from SEC (XBRL) filings.
What is Liquidia Corporation Common Stock's Revenue (TTM)?
Liquidia Corporation Common Stock's Revenue (TTM) is $450.9M, based on as-reported figures from SEC (XBRL) filings.
What is Liquidia Corporation Common Stock's Net Income (TTM)?
Liquidia Corporation Common Stock's Net Income (TTM) is $138.6M, based on as-reported figures from SEC (XBRL) filings.
What is Liquidia Corporation Common Stock's EBITDA?
Liquidia Corporation Common Stock's EBITDA is $170.3M, based on as-reported figures from SEC (XBRL) filings.
What is Liquidia Corporation Common Stock's Diluted EPS (TTM)?
Liquidia Corporation Common Stock's Diluted EPS (TTM) is 1.55, based on as-reported figures from SEC (XBRL) filings.
What is Liquidia Corporation Common Stock's EBITDA Margin?
Liquidia Corporation Common Stock's EBITDA Margin is 37.8%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Condensed Consolidated Statements of Operations and Comprehensive Loss
Total revenue
YoY growth+1842.7%+4158.5%+3054.6%+1121.7%
Costs and expenses:
Cost of revenue————
Research and development
Selling, general and administrative
Total costs and expenses
% of revenue50.2%53.7%78.5%96.7%
Income (loss) from operations
% of revenue49.8%46.3%21.5%3.3%
Other income (expense):
Interest income
Interest expense
Total other expense, net
Income (loss) before income taxes——
Income tax expense——
Net income (loss) and comprehensive income (loss)
% of revenue43.5%39.8%15.8%-6.5%
Net income (loss) per common share, basic (in dollars per share)
Net income (loss) per common share, diluted (in dollars per share)